Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide (Saxenda) for weight management in forensic psychiatry
2020-003718-11Phase 4Completed
- Sponsor
- Psykiatrisk Center København
- Start
- Aug 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liraglutide in obesity, Overweight and Chronic mental illness (CMI), sponsored by Psykiatrisk Center København. Primary endpoint: Number of completers. Started Aug 2020; status: completed.
02
Drugs
03
Conditions
obesityOverweightChronic mental illness (CMI)
Beyond the preview
Go deeper on 2020-003718-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003718-11.